Familial Testotoxicosis: Clinical Trials

2 trials for Familial Testotoxicosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Familial Testotoxicosis: new trials by email Literature Review of Familial Testotoxicosis trials Research Report on Familial Testotoxicosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural History Study of Patients With Excess Androgen
Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP)
RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)30002006-01-022026-09-08
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Bicalutamide, Anastrozole - Puberty, Precocious
Phase 2CompletedAstraZeneca142004-11-222018-06-26

Narrower conditions

Puberty, Precocious (2)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Adrenal Insufficiency (1)  ·  Congenital adrenal hyperplasia due to 21 hydroxylase deficiency (1)

Broader conditions

Endocrine System Diseases (2)  ·  Gonadal Disorders (2)  ·  Adrenal Gland Diseases (1)  ·  Adrenogenital Syndrome (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disorders of Sex Development (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Steroid Metabolism, Inborn Errors (1)

Interventions

Anastrozole (1)  ·  bicalutamide (1)

Sponsors

AstraZeneca (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)  ·  India (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Deborah P Merke, M.D. (1)  ·  Yuri E Rukazenkov, MD (1)

Results publications

PMID 22904181, PMID 22990093, PMID 26075496, PMID 28472487, PMID 30465166, PMID 33677504, PMID 36833192, PMID 38405151